Oberschleissheim – 10-30-2020 (PRDistribution.com) — First-of-its-kind consortium made up of healthcare industry leaders aims to establish standards for RFID use.
Schreiner MediPharm, a leader in the development and manufacture of innovative specialty labels, today announced that it has joined DoseID, the first member driven industry consortium for the use of radio-frequency identification (RFID) technology in the healthcare space. DoseID consists of industry innovators who are committed to increasing the interoperability, quality and performance of RFID-tagged products as they move through the pharmaceutical supply chain from manufacturer to patient. The DoseID RFID tag certification will be provided by Auburn University RFID Lab’s ARC Program. This ensures that parties not only meet the standards set by the consortium, but that the established standards meet the needs of industry players including pharmaceutical manufacturers, 503b compounding pharmacies, pharmacy automation vendors, and inlay and tag manufacturers. Members of DoseID, which launched in August 2020, hail from other companies across the spectrum including Omnicell Inc., Sandoz, Baxter, Hikma, Leiters, Nephron Pharmaceuticals, Avery Dennison, Kit Check and others.“As a long-term provider of customized RFID labels for the healthcare industry we see the need for interoperability and quality standards as essential to leverage the full potential of RFID. We are looking forward to be part of the DoseID consortium to mutually drive RFID-based smart solutions to enhance the pharmaceutical supply chain.” said Stefan Wiedemann, Senior Director Strategic Marketing and Business Development at Schreiner MediPharm. DoseID takes serialization beyond DSCSA, from the unit of sale to the unit of use. It uniquely serializes every dose, container, or device to track each action taken upon it during its entire lifecycle and ensures RFID tagged drugs work in all downstream IT systems in hospitals and health systems. The organizations that make up DoseID collectively account for the majority of the existing RFID tagging market, positioning the consortium well to combat the challenges associated with unit level drug visibility. Some of the concepts of DoseID have already been shown to be successful, with more than 120 million tagged units in the field to-date and a recent pilot with the FDA associated with DSCSA compliance.It is only with participation across the entire pharmaceutical supply chain that RFID unit-level medication tracking can achieve the DoseID goals of interoperability, reliable tag performance and complete and accurate data. Schreiner MediPharm designs and manufactures reliable, high-performance RFID labels that allow a frictionless integration and smooth processing on unit-level pharmaceutical packaging lines – improving the automation of processes to increase efficiency, but most importantly to enhance patient and drug safety.To learn more about Schreiner MediPharm, visit www.schreiner-medipharm.com. To learn more about DoseID, please visit doseid.com.
About Schreiner MediPharm:Schreiner MediPharm, a business unit of Schreiner Group based in Oberschleissheim near Munich (Germany) and Blauvelt, New York, is a leader in the development and manufacture of innovative specialty labels with value-added benefits for the pharmaceutical and medical device industry. The product portfolio includes labels with integrated hangers, with detachable parts and multi-page labels. Additionally, the company offers anti-tampering and counterfeiting protection solutions as well as NFC/RFID labels and smart packaging solutions. These products simplify dispensing and administering of pharmaceuticals, enhance drug safety and clearly reduce process costs. Thanks to its strong solutions expertise and specialized know-how Schreiner MediPharm is a highly capable development partner and quality supplier to leading pharmaceutical companies worldwide. In the field of label-integrated RFID solutions, Schreiner MediPharm cooperates with renowned inlay and technology providers and develops customized antenna and label designs that are optimized for diverse use cases. Unique, highly robust yet flexible RFID-Labels ensure easy integration into the pharma manufacturer’s production and handling processes while providing reliable functionality from production through end use.
For the original news story, please visit https://prdistribution.com/news/schreiner-medipharm-joins-doseid-to-further-expand-rfid-interoperability-in-healthcare.html.